2020
Utilization and cost of topical calcineurin inhibitors in the Medicare population: 2013 to 2017
Ugwu N, Cheraghlou S, Cohen JM. Utilization and cost of topical calcineurin inhibitors in the Medicare population: 2013 to 2017. Journal Of The American Academy Of Dermatology 2020, 85: 1345-1346. PMID: 33137441, DOI: 10.1016/j.jaad.2020.10.074.Peer-Reviewed Original ResearchAdministration, TopicalCalcineurin InhibitorsHumansImmunosuppressive AgentsMedicareTacrolimusUnited States
2016
Cost-effectiveness of Confirmatory Testing Before Treatment of Onychomycosis
Mikailov A, Cohen J, Joyce C, Mostaghimi A. Cost-effectiveness of Confirmatory Testing Before Treatment of Onychomycosis. JAMA Dermatology 2016, 152: 1-6. PMID: 26716567, DOI: 10.1001/jamadermatol.2015.4190.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, OralAdministration, TopicalAlgorithmsCost SavingsCost-Benefit AnalysisDecision Support TechniquesDecision TreesHealth Care CostsHumansHydroxidesNaphthalenesOnychomycosisPeriodic Acid-Schiff ReactionPotassium CompoundsPotentially Inappropriate Medication ListTerbinafineTriazolesConceptsConfirmatory testingOral terbinafineSystemic therapyDirect patient evaluationLiver toxic effectsPatient cost savingsPotassium hydroxide (KOH) stainDisease prevalenceTreatment of onychomycosisConfirmatory diagnostic testingHealth care professionalsPrevalence of diseaseTerbinafine therapyEmpirical therapyPretreatment testingPrimary outcomePatient evaluationSpecific therapyEmpirical treatmentMAIN OUTCOMECare professionalsInternational guidelinesTherapyDiagnostic testingPatient safety